Sector Watch: Healthcare - May 16 2018
This is an archive page. To See the most recent Healthcare Sectorwatch click here
IBB: $107.53 +0.95 0.89% | XBI: $93.46 +1.18 1.28% | Updated May 16, 2018 04:26 PM
| HEALTHCARE STOCKS - TOP GAINERS | ||||
|---|---|---|---|---|
| VVUS VIVUS $72.4M |
0.66+0.14 6.8 M 7.5x |
27% | ||
| EBIO Eleven Biotherapeutics $166.7M |
3.29+0.64 15.6 M 2.6x |
24% | ||
| PTIE Pain Therapeutics $69.0M |
10.62+1.47 314.8 K 5.5x |
16% | ||
| VKTX Viking Therapeutics $263.0M |
5.13+0.55 2.0 M 2.5x |
12% | ||
| GTXI GTx $421.7M |
18.43+1.78 1.8 M 25.4x |
11% | ||
| HEALTHCARE STOCKS - TOP LOSERS | ||||
|---|---|---|---|---|
| OMER Omeros $896.2M |
20.01-4.43 4.1 M 3.3x |
-18% | ||
| VSTM Verastem $230.9M |
4.61-0.63 7.4 M 5.9x |
-12% | ||
| AST Asterias Biotherapeutics $84.5M |
1.65-0.15 484.9 K 2.6x |
-8% | ||
| PFNX Pfenex $132.2M |
7.35-0.65 286.6 K 2.7x |
-8% | ||
| CYAD52WL Celyad SA $303.3M |
28.25-2.47 3.6 K |
-8% | ||
Not for trading - Data delayed up to 20 minutes from last update time.
Excludes companies with market caps below $50M.
Market Caps next to company names. Trading volumes below stock prices.
NNx - unusual volume NN times the 3-month avg. volume
52WL - 52-week Low in this trading session
52WH - 52-week High in this trading session
Healthcare Stocks Related News
Verastem Oncology Announces Pricing of Public Offering of Common Stock | Business Wire [businesswire.com]Eleven Biotherapeutics Announces Corporate Name Change to Sesen Bio | Business Wire [businesswire.com]
Asterias Biotherapeutics to Discuss Cancer Immunotherapy Product AST-VAC2 at the World Advanced Therapies and Regenerative Medicine Congress [globenewswire.com]
EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S. [globenewswire.com]
Global Pain Therapeutics Report 2017-2027: Latest Concepts of Pathomechanisms of Pain as a Basis for Management and Development of New Pharmacotherapies for Pain [prnewswire.com]
Updated 2018 Report: Pain Therapeutics Drugs, Markets and Companies Analysis & Forecast 2017-2027 - 173 Company Profiles with 154 Collaborations - ResearchAndMarkets.com | Business Wire [businesswire.com]
Verastem Oncology Announces Pricing of Public Offering of Common Stock [businesswire.com]
GTX Corp First Quarter 2018 Summary [globenewswire.com]
Eleven Biotherapeutics Reports First Quarter Financial Results and Pipeline Updates | Business Wire [businesswire.com]
Celyad Announces Launch of Proposed Global Offering | Business Wire [businesswire.com]
Verastem Oncology Announces Public Offering of Common Stock | Business Wire [businesswire.com]
Celyad Announces First Quarter 2018 Business Update [globenewswire.com]
Celyad announces launch of proposed global offering [globenewswire.com]
Verastem Oncology Announces Public Offering of Common Stock [businesswire.com]
GTx Provides Corporate Update and Reports First Quarter 2018 Financial Results | Business Wire [businesswire.com]
Grotrax Wins "Best in Class" Gold Award at 2018 National Hardware Show [prnewswire.com]
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for [prnewswire.com]
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018 [prnewswire.com]
Cara Therapeutics to Present at the International Investigative Dermatology 2018 Meeting [globenewswire.com]
TimeFireVR Provides Update on Bitcoin Mining Operation and Expansion Strategy [globenewswire.com]
HP Accelerates Innovation with Stunning Lineup of Premium PCs [globenewswire.com]
Omeros Corporation Reports First Quarter 2018 Financial Results | Business Wire [businesswire.com]
BioTime Reports First Quarter Results and Recent Corporate Accomplishments | Business Wire [businesswire.com]
Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update [prnewswire.com]
Cara Therapeutics Reports First Quarter 2018 Financial Results [globenewswire.com]
Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY® ER [globenewswire.com]
Celyad Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2018 [globenewswire.com]
Ligand Reports First Quarter 2018 Financial Results | Business Wire [businesswire.com]
Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results [prnewswire.com]
Stock Performance Review on Biotech Industry -- Neptune Technologies & Bioressources, NewLink [prnewswire.com]
Stock Performance Review on Biotech Industry -- Neptune Technologies & Bioressources, NewLink Genetics, OHR Pharma, and Omeros [prnewswire.com]
Omeros Corporation to Announce First Quarter 2018 Financial Results on May 10, 2018 | Business Wire [businesswire.com]
Disclaimer Red Acre Investments is not a registered investment advisor and the views and opinions offered herein do not constitute investment advice. Investors should always conduct their own due diligence before trading. You should assume that Red Acre is trading the securities mentioned in our Red Acre Insights, generally in accordance with the views we express, although our positions may change as news evolves. We do not undertake any obligation to update our views as market conditions evolve.
